反応式
[C:1]([NH:5][C:6]([C:8]1[C:16]2[C:11](=[N:12][CH:13]=[C:14]([C:17]3[C:25]4[C:20](=[CH:21][CH:22]=[C:23]([C:26]#[N:27])[CH:24]=4)[N:19]([CH3:28])[N:18]=3)[N:15]=2)[N:10](COCC[Si](C)(C)C)[CH:9]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2].FC(F)(F)C(O)=O.C(N)CN.O>ClCCl.C(OCC)(=O)C>[C:1]([NH:5][C:6]([C:8]1[C:16]2[C:11](=[N:12][CH:13]=[C:14]([C:17]3[C:25]4[C:20](=[CH:21][CH:22]=[C:23]([C:26]#[N:27])[CH:24]=4)[N:19]([CH3:28])[N:18]=3)[N:15]=2)[NH:10][CH:9]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
In a round-bottomed flask, 2-(5-cyano-1-methyl-1H-indazol-3-yl)-5-(2-trimethylsilanylethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide (80 mg, 0.16 mmol) was dissolved in dichloromethane (0.8 ml) and trifluoroacetic acid (0.5 ml, 6.4 mmol) was added. The reaction mixture was stirred at room temperature for 2 h then concentrated. The residue was suspended in dichloromethane (0.8 ml) and ethylenediamine (0.65 ml, 9.63 mmol) was added. The light yellow suspension was stirred at room temperature for 1 h then water and ethyl acetate were added. The suspension was filtered and washed with hot water and ethyl acetate. The product collected was dried under high vacuum to provide 43 mg (73%) of 2-(5-cyano-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide as a yellow powder. MS: (M+Na)+=396; 1H NMR (DMSO-d6, 300 MHz): δ (ppm) 12.48 (br. s., 1H), 9.10 (s, 1H), 8.87 (s, 1H), 8.41 (s, 1H), 7.93-8.05 (m, 1H), 7.78-7.90 (m, 2H), 4.23 (s, 3H), 1.54 (s, 9H).
後処理
- concentrationthen concentrated
- stirringThe light yellow suspension was stirred at room temperature for 1 h
- filtrationThe suspension was filtered
- washwashed with hot water and ethyl acetate
- customThe product collected
- customwas dried under high vacuum
出典と根拠
- ORDレコード
- ord-38240a3ce6c34b9bb5a5e9bd8e1815e0
- 出典データセット
- uspto-grants-2014_02
- 特許番号
- US08658646B2
関連ノート
読み込み中…